These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Chen Y; Gao DY; Huang L Adv Drug Deliv Rev; 2015 Jan; 81():128-41. PubMed ID: 24859533 [TBL] [Abstract][Full Text] [Related]
6. The role of microRNAs in ovarian function and the transition toward novel therapeutic strategies in fertility preservation: from bench to future clinical application. Alexandri C; Daniel A; Bruylants G; Demeestere I Hum Reprod Update; 2020 Feb; 26(2):174-196. PubMed ID: 32074269 [TBL] [Abstract][Full Text] [Related]
7. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics. Cuciniello R; Filosa S; Crispi S J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235 [TBL] [Abstract][Full Text] [Related]
9. Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. McKiernan PJ; Cunningham O; Greene CM; Cryan SA Int J Nanomedicine; 2013; 8():3907-15. PubMed ID: 24143095 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA therapeutics: principles, expectations, and challenges. Rupaimoole R; Han HD; Lopez-Berestein G; Sood AK Chin J Cancer; 2011 Jun; 30(6):368-70. PubMed ID: 21627858 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Rupaimoole R; Slack FJ Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology. Awasthi R; Rathbone MJ; Hansbro PM; Bebawy M; Dua K Drug Deliv Transl Res; 2018 Feb; 8(1):97-110. PubMed ID: 29185148 [TBL] [Abstract][Full Text] [Related]
14. Progresses in microRNA Delivery Using Synthetic Nanovectors in Cancer Therapy. Javanmardi S; Aghamaali MR; Abolmaali SS; Tamaddon AM Curr Pharm Des; 2018; 24(31):3678-3696. PubMed ID: 30465494 [TBL] [Abstract][Full Text] [Related]
15. Trials and Tribulations of MicroRNA Therapeutics. Seyhan AA Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as targets for antisense-based therapeutics. Stenvang J; Kauppinen S Expert Opin Biol Ther; 2008 Jan; 8(1):59-81. PubMed ID: 18081537 [TBL] [Abstract][Full Text] [Related]
17. Exploiting microRNAs As Cancer Therapeutics. Robb T; Reid G; Blenkiron C Target Oncol; 2017 Apr; 12(2):163-178. PubMed ID: 28138797 [TBL] [Abstract][Full Text] [Related]
18. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention. Sengupta D; Deb M; Kar S; Pradhan N; Parbin S; Kirtana R; Singh SP; Suma SG; Niharika ; Roy A; Manna S; Saha P; Chakraborty P; Dash S; Kausar C; Patra SK Semin Cancer Biol; 2021 Jul; 72():46-64. PubMed ID: 32497683 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention. Holjencin C; Jakymiw A Cells; 2022 Jul; 11(15):. PubMed ID: 35954176 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of non-coding RNAs in cancer. Slaby O; Laga R; Sedlacek O Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]